Immunome 

Yahoo Finance • 5 days ago

Nurix Stock Is Down 6% This Past Year, but One Biotech Fund Still Boosted Its Bet By $63 Million

On February 17, 2026, Redmile Group disclosed a buy of 4,415,514 Nurix Therapeutics(NASDAQ:NRIX) shares, an estimated $63.43 million trade based on quarterly average pricing. What happened According to a Securities and Exchange Commissio... Full story

Yahoo Finance • 5 days ago

Biotech-Focused Fund Adds $12 Million to Immunome Bet as Stock Surges 120%

On February 17, 2026, Redmile Group disclosed a buy of 695,000 shares of Immunome(NASDAQ:IMNM), an estimated $12.20 million trade based on quarterly average pricing. What happened According to a February 17, 2026, SEC filing, Redmile Gro... Full story

Yahoo Finance • 5 days ago

Investor Slashes $70 Million From Zymeworks as Stock Jumps 60% in a Year

Redmile Group disclosed a significant reduction in its Zymeworks(NASDAQ:ZYME) position in a February 17, 2026, SEC filing, selling an estimated $70.10 million in shares based on quarterly average pricing. What happened According to a Feb... Full story

Yahoo Finance • 5 days ago

Biotech Investor Adds $3 Million to Krystal Biotech as Revenue Hits $389 Million in 2025

Redmile Group reported a purchase of 16,317 shares of Krystal Biotech(NASDAQ:KRYS) in its February 17, 2026, SEC filing, with the estimated transaction value at $3.43 million based on quarterly average pricing. What happened According to... Full story

Yahoo Finance • 5 days ago

Biotech Fund Doubles Down With $49 Million Scholar Rock Buy as Shares Climb 26%

Redmile Group disclosed a buy of 1,316,390 shares of Scholar Rock Holding Corporation(NASDAQ:SRRK) in a February 17, 2026, SEC filing, with the estimated transaction value at $49.37 million based on quarterly average pricing. What happene... Full story

Yahoo Finance • 15 days ago

Shopify upgraded, Coinbase downgraded: Wall Street's top analyst calls

The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as compiled by The Fly. Top 5 Upgrades: TD Cowen upgraded Shopify (SHOP) to Bu... Full story

Yahoo Finance • 2 months ago

Weekly Buzz: CYTK Scores First FDA Approval, INSM Ends Rhinosinusitis Study, XOMA Acquires GBIO

(RTTNews) - The biotech industry witnessed several key events this week, including major FDA approvals, acquisitions, pivotal clinical trial results and setbacks. • A series of FDA approvals were announced during the week, with GSK, Haloz... Full story

Yahoo Finance • 2 months ago

Immunome prices $400M stock offering at $21.50 a share

Immunome (IMNM [https://seekingalpha.com/symbol/IMNM]) has priced a public offering [https://seekingalpha.com/pr/20342088-immunome-announces-pricing-of-public-offering-of-common-stock] of 18.63 million shares at $21.50 per share. The compa... Full story

Yahoo Finance • 2 months ago

Cancer Drug Developers Secure Regulatory Clarity as FDA Reshapes Approval Standards

VANCOUVER, British Columbia, Dec. 16, 2025 (GLOBE NEWSWIRE) -- Equity-Insider.comNews Commentary – The FDA is moving to require just one clinical trial for new drug approvals, signaling a dramatic shift toward faster regulatory pathways... Full story

Yahoo Finance • 2 months ago

Stocks Fall Ahead of US November Payroll Report

The S&P 500 Index ($SPX) (SPY) on Monday closed down by -0.16%, the Dow Jones Industrials Index ($DOWI) (DIA) closed down by -0.09%, and the Nasdaq 100 Index ($IUXX) (QQQ) closed down by -0.51%.  December E-mini S&P futures (ESZ25) fell -0... Full story

Yahoo Finance • 2 months ago

Sector Update: Health Care Stocks Rise in Afternoon Trading

Health care stocks rose Monday afternoon, with the NYSE Health Care Index up 0.9% and the State Stre PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • 2 months ago

Stock Market Today: Russell 2000, Nasdaq Decline After Strong Start to Trading Week

This live blog is refreshed periodically throughout the day with the latest updates from the market.To find the latest Stock Market Today threads, click here. Happy Monday. This is TheStreet’s Stock Market Today for Dec. 15, 2025. You can... Full story

Yahoo Finance • 2 months ago

Stocks making the biggest moves midday: Zillow, KLA, iRobot, Immunome & more

Check out the companies making the biggest moves midday: KLA Corp. — The semiconductor equipment maker jumped 4%, nearing a 52-week high, after Jefferies raised its 12-month price target to $1,500 from $1,200, saying "AI continues to drive... Full story

Yahoo Finance • 2 months ago

Stocks Climb in Anticipation of Fed-Friendly US Economic News

The S&P 500 Index ($SPX) (SPY) today is up by +0.39%, the Dow Jones Industrials Index ($DOWI) (DIA) is up by +0.27%, and the Nasdaq 100 Index ($IUXX) (QQQ) is up by +0.50%.  December E-mini S&P futures (ESZ25) are up +0.40%, and December E... Full story

Yahoo Finance • 2 months ago

Why Immunome, A Top 3% Stock, Just Rocketed On Its Rivalry With Merck KGaA

Top-notch biotech stock Immunome rocketed Monday after the company's treatment for desmoid tumors appeared to top an approved drug. Continue Reading... Full story

Yahoo Finance • 4 months ago

Immunome GAAP EPS of -$0.65

* Immunome press release [https://seekingalpha.com/pr/20297808-immunome-reports-third-quarter-2025-financial-results-and-provides-business-update] (IMNM [https://seekingalpha.com/symbol/IMNM]): Q3 GAAP EPS of -$0.65. * As of September... Full story

Yahoo Finance • 4 months ago

First Week of December 19th Options Trading For Zscaler (ZS)

Investors in Zscaler Inc (Symbol: ZS) saw new options begin trading this week, for the December 19th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ZS options chain for the new December 19th contr... Full story

Yahoo Finance • 7 months ago

ASP Isotopes Inc. and IsoBio, Inc. Announce Series Seed Funding of IsoBio, Inc. to Advance Innovative Antibody-Isotope Conjugates (AICsTM) For Cancer Treatment

- IsoBio, Inc. (IsoBio) is a U.S.-based radiotherapeutic development company focused on developing a broad pipeline of mAb-based radioisotope therapeutics, known as antibody-isotope conjugates (AICsTM), targeting both derisked and novel tu... Full story

Yahoo Finance • 3 years ago

INVESTIGATION ALERT: Halper Sadeh LLC Investigates KDNY, WMC, AJX, IMNM

NEW YORK, July 11, 2023 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholde... Full story

Yahoo Finance • 3 years ago

ALERT: The M&A Class Action Firm Continues Investigating the Merger – AEL, AJX, IMNM, SGTX

NEW YORK, July 10, 2023 (GLOBE NEWSWIRE) -- Juan Monteverde, founder and managing partner of the class action firm Monteverde & Associates PC (the “M&A Class Action Firm”), a national securities firm rated Top 50 in the 2018-2021 ISS Se... Full story